Warith Takes Part in the "We Meet So Iraq Can Rise" Conference

Warith Takes Part in the "We Meet So Iraq Can Rise" Conference

Dr. Mourad Mohamad (PhD in Radiation Oncology), a member of the Warith staff, delivered a lecture on bone tumors at the "We Meet So Iraq Can Rise" conference. The conference was organized by the Karbala Society of Orthopedic and Fracture Surgeons in cooperation with the Karbala Health Directorate to mark the 9th World Orthopedic and Fracture Surgery Day. In his lecture, Dr. Mourad discussed the role of radiotherapy in treating soft tissue sarcoma, highlighting the advantages of giving radiation before surgery rather than after it.

Radiotherapy is a common treatment for soft tissue sarcoma. It uses high-energy X-rays to destroy cancer cells. Radiotherapy given before surgery, known as neoadjuvant radiotherapy, aims to shrink the sarcoma, making it easier to remove surgically and possibly allowing a smaller operation. In addition, radiotherapy before surgery may help reduce the risk of the cancer coming back in the future.

Related news

  • Warith localize manufacturing of biological, cellular, and gene therapies in Iraq through 3 U.S. partnerships

    We announce the conclusion of three strategic partnerships with specialized U.S. entities, aimed at localizing the manufacturing technologies for biopharmaceuticals and cell and gene therapies inside Iraq — a step described as a qualitative leap in the development of the national health sector. Dr. Haider Hamza Al-Abidi, Head of the Health and Medical Education Authority at the Holy Imam Hussain Shrine, said the agreements, concluded during his visit to the United States, include the provision of a modern bioreactor and its laboratory supplies in partnership with the global company Thermo Fisher, in addition to a clinical and training partnership with Boston Children's Hospital, the primary teaching affiliate of Harvard University, as well as an agreement with a partner specialized in transferring technologies locally to ensure the integration of the therapeutic system. He affirmed that the project builds on a supportive infrastructure, including bone marrow transplant procedures at Al-Mujtaba Hospital and the international accreditation of the Warith Foundation, noting that these partnerships will contribute to providing advanced treatments inside Iraq at prices lower than their global counterparts, and to ending reliance on sending patients abroad for specialized treatments, particularly children with cancers and complex diseases.

All news